REGENXBIO Inc. today announced that it will host a conference call on Thursday, March 5, at 8:00 a.m. ET to discuss its financial results for the fourth quarter and full year ended December 31, 2025, ...
BreezeBio, Inc., formerly known as GenEdit, today announced the close of $60 million in Series B financing to advance its first internal therapeutic programs toward the clinic and to continue ...
Groundbreaking neurocognition research is sharpening the scientific focus on a once little-understood process in early childhood: myelination. As studies reveal how this critical brain mechanism ...
A behavioral neurologist is seeing more patients whose carefully curated brain-health supplement stacks may be doing the opposite of what they intended — and the science behind why is something the ...
This part of the brain is responsible for self-control, problem-solving, and flexible thinking, and it is often weakened by ...
Morning Overview on MSN
Biohackers push wild nicotine stacks as the next extreme wellness hack
Online wellness communities are rebranding nicotine pouches as a cognitive performance tool, stacking them alongside ...
About Alpha Cognition Inc. Alpha Cognition Inc. is a pre-commercial stage, biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as ...
Rutgers researchers are launching a clinical trial to explore whether alpha-linolenic acid (ALA)-enriched nutrition can improve memory and brain health in older adults with mild cognitive impairment ...
Cal Bewicke of Ethical Naturals highlights research examining both the immediate and long-term effects of AlphaWave® ...
Alpha Cognition Inc is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer’s disease, for which there are limited ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results